ABBV

AbbVie Inc

drug manufacturers - general

Current price

$248.08

+33.78% over 1Y

Ticker pages are provided for informational and educational purposes.

Market cap

$438.31B

Exchange

NYSE

Headquarters

IL, UNITED STATES

About ABBV

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Latest news

Sourced via Alpha Vantage

ad-hoc-news.de · 9h ago

AbbVie stock holds steady after a new U.S. market backdrop

The Globe and Mail · 16h ago

AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty

The Motley Fool · 22h ago

Which is the Better Choice for Healthcare Investors? IYH or BBH?

The Globe and Mail · 23h ago

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

The Globe and Mail · 1d ago

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Eli Lilly & Co (LLY)

Moomoo · 1d ago

BofA Securities Upgrades AbbVie(ABBV.US) to Buy Rating, Raises Target Price to $276

Simply Wall Street · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced?

Simply Wall Street · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced?